Connor, Clark & Lunn Investment Management (CC&L)’s Teladoc Health TDOC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.2M Sell
1,510,823
-47,546
-3% -$414K 0.05% 334
2025
Q1
$12.4M Buy
1,558,369
+200,494
+15% +$1.6M 0.05% 279
2024
Q4
$12.3M Sell
1,357,875
-343,286
-20% -$3.12M 0.06% 271
2024
Q3
$15.6M Buy
1,701,161
+228,004
+15% +$2.09M 0.08% 197
2024
Q2
$14.4M Buy
1,473,157
+154,982
+12% +$1.52M 0.06% 231
2024
Q1
$19.9M Buy
1,318,175
+681,496
+107% +$10.3M 0.09% 205
2023
Q4
$13.7M Sell
636,679
-21,756
-3% -$469K 0.06% 237
2023
Q3
$12.2M Buy
658,435
+57,989
+10% +$1.08M 0.06% 232
2023
Q2
$15.2M Sell
600,446
-74,290
-11% -$1.88M 0.08% 195
2023
Q1
$17.5M Sell
674,736
-703
-0.1% -$18.2K 0.09% 175
2022
Q4
$16M Sell
675,439
-17,930
-3% -$424K 0.09% 169
2022
Q3
$17.6M Buy
693,369
+341,471
+97% +$8.66M 0.12% 137
2022
Q2
$11.7M Buy
351,898
+316,492
+894% +$10.5M 0.07% 186
2022
Q1
$2.55M Buy
+35,406
New +$2.55M 0.01% 448